Scottsdale, United States
Regenesis is a pioneering company in the Biotechnology and Medical Devices industry, offering a unique solution for pain management without the use of drugs, empowering patients to self-treat at home. Founded in 1997 and headquartered in the United States, the company focuses on energy-based medical products designed to improve quality of life. Their mission aligns with core values such as dedication, innovation, and compassion.
The company's last investment was a $5.30M Series C round completed on 06 June 2011, with backing from significant investors including Fulcrum Equity Partners, Solstice Capital, and TGap Ventures. Despite its longstanding presence in the industry, Regenesis presents a stable investment opportunity for those looking to support a business committed to innovation in healthcare solutions. Their focus on non-pharmacological treatment options could capture a growing market demand for safer, more independent healthcare approaches.
